Cargando…

Programmed cell death in stem cell-based therapy: Mechanisms and clinical applications

Stem cell-based therapy raises hopes for a better approach to promoting tissue repair and functional recovery. However, transplanted stem cells show a high death percentage, creating challenges to successful transplantation and prognosis. Thus, it is necessary to investigate the mechanisms underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xi-Min, Zhang, Qi, Zhou, Rui-Xin, Wu, Yan-Lin, Li, Zhi-Xin, Zhang, Dan-Yi, Yang, Yi-Chao, Yang, Rong-Hua, Hu, Yong-Jun, Xiong, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176847/ https://www.ncbi.nlm.nih.gov/pubmed/34136072 http://dx.doi.org/10.4252/wjsc.v13.i5.386

Ejemplares similares

A systematic summary of survival and death signalling during the life of hair follicle stem cells
por: Hu, Xi-Min, et al.
Publicado: (2021)

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
por: Wan, Xin-Xing, et al.
Publicado: (2022)

Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases
por: Zhang, Qi, et al.
Publicado: (2021)

Current research and clinical trends in rosacea pathogenesis
por: Hu, Xi-Min, et al.
Publicado: (2022)

The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis
por: Wu, Hong-wei, et al.
Publicado: (2023)

The Hydrogen Sulfide Donor NaHS Delays Programmed Cell Death in Barley Aleurone Layers by Acting as an Antioxidant
por: Zhang, Ying-Xin, et al.
Publicado: (2015)

Sulfur dioxide alleviates programmed cell death in barley aleurone by acting as an antioxidant
por: Wang, Sha-Sha, et al.
Publicado: (2017)

Programmed Cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis
por: Hu, Qiong-ying, et al.
Publicado: (2021)

Programmed Cell Death Tunes Tumor Immunity
por: Liu, Jing, et al.
Publicado: (2022)

Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective
por: Hu, Xi-min, et al.
Publicado: (2021)

New Advance in Caspase-Independent Programmed Cell Death and its Potential in Cancer Therapy
por: Qi, Rong, et al.
Publicado: (2006)

Recent Advancements in Toxin and Antitoxin Systems Involved in Bacterial Programmed Cell Death
por: Hu, Ming-xi, et al.
Publicado: (2010)

Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
por: Zheng, Lin-Lin, et al.
Publicado: (2021)

Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8(+) T-cell immune responses
por: Zhu, Ying, et al.
Publicado: (2018)

Programmed cell death and its role in inflammation
por: Yang, Yong, et al.
Publicado: (2015)

The regulatory role of Pin1 in neuronal death
por: Wang, Shu-Chao, et al.
Publicado: (2022)

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas
por: Zeng, Jing, et al.
Publicado: (2016)

The overall safety evaluation of programmed cell death/programmed cell death ligand 1 (PD-1/PD-L1) treatment for lung cancer patients: An updated systematic review and meta-analysis
por: Shang, Heli, et al.
Publicado: (2019)

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019)

Programmed death-1 expression and regulatory T cells increase in the Intestinal mucosa of cytomegalovirus colitis in patients with HIV/AIDS
por: Sun, Lei, et al.
Publicado: (2020)

Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis
por: Yang, Ting, et al.
Publicado: (2020)

Plasma membrane changes during programmed cell deaths
por: Zhang, Yingying, et al.
Publicado: (2018)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons
por: Yan, Wei-Tao, et al.
Publicado: (2022)

Recent advances in isolation, identification, and culture of mammalian spermatogonial stem cells
por: Xi, Hua-Ming, et al.
Publicado: (2021)

Seneca Valley virus 3C(pro) antagonizes host innate immune responses and programmed cell death
por: Zhang, Xin-yu, et al.
Publicado: (2023)

Insights into N6-methyladenosine and programmed cell death in cancer
por: Liu, Li, et al.
Publicado: (2022)

Regulation of programmed cell death by Brd4
por: Hu, Jinfeng, et al.
Publicado: (2022)

No Effect on Tumorigenesis in MG63 Cells Induced by Co-Cultured Mesenchymal Stem Cells
por: Xing, Xin, et al.
Publicado: (2022)

Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: A bidirectional Mendelian randomization study
por: Huang, Yu-Feng, et al.
Publicado: (2023)

Exosomes From Adipose-Derived Stem Cells: The Emerging Roles and Applications in Tissue Regeneration of Plastic and Cosmetic Surgery
por: Xiong, Mingchen, et al.
Publicado: (2020)

Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery
por: Sui, Bing-Dong, et al.
Publicado: (2018)

Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus
por: Yang, Fangyuan, et al.
Publicado: (2019)

Role of programmed death ligands in effective T-cell interactions in extranodal natural killer/T-cell lymphoma
por: HAN, LIJUAN, et al.
Publicado: (2014)

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)

Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration
por: Wang, Ruirui, et al.
Publicado: (2021)

Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia
por: Sui, Bing-Dong, et al.
Publicado: (2017)

Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
por: Wen, Lei, et al.
Publicado: (2013)

Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 Immunotherapy
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_735935mheq0h16eetgtvhkqpnj